| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | Australia | 2 | |
| #3 | United States | 2 | |
| #4 | Canada | 1 | |
| #5 | China | 1 | |
| #6 | EPO (European Patent Office) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Medical technology | |
| #4 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Heterocyclic compounds | |
| #4 | Peptides | |
| #5 | Electrotherapy |
| # | Name | Total Patents |
|---|---|---|
| #1 | Aronsen Jan Magnus | 6 |
| #2 | Skogestad Jonas | 6 |
| #3 | Krauss Stefan | 2 |
| #4 | Waaler Jo | 2 |
| #5 | Fallang Lars-Egil | 1 |
| #6 | Wegert Anita | 1 |
| #7 | Lundin Knut | 1 |
| #8 | Voronkov Andrey Edward | 1 |
| #9 | Leenders Ruben Gerardus George | 1 |
| #10 | Lehtio Lari | 1 |
| Publication | Filing date | Title |
|---|---|---|
| EP3713572A1 | Treatment of tachycardia | |
| WO2018118868A1 | Triazole derivatives as tankyrase inhibitors | |
| WO2017191504A1 | Validation of therapeutic t-cells | |
| WO2017158393A1 | Methods of treating graft-versus-host disease |